News
Can benefits of SBRT outweigh risks in ultra-central lung tumors?
- Author:
- Sara Freeman
Stereotactic body radiotherapy for ultra-central lung tumors offers good disease control and survival but carries a risk of lung hemorrhage.
News
KRYSTAL-1: Clear activity of adagrasib in KRAS-mutated NSCLC
- Author:
- Sara Freeman
Phase 1/2 results with adagrasib confirm KRAS G12C as a druggable target in non–small cell lung cancer.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Anolik_Jennifer_NY_web.jpg)
RA expert updates latest pathologic findings from Accelerating Medicines Partnership
- Author:
- Sara Freeman
Researchers have used single-cell analytic techniques to reveal pathologic RA synovial tissue differences in stromal and immune cells between...
News
No benefit seen with everolimus in early breast cancer
- Author:
- Sara Freeman
There were no improvements in survival when everolimus was added to hormone therapy.
News
![](https://www.qa.mdedge.com/sites/all/modules/contrib/lazyloader/image_placeholder.gif)
OA risk-reduction program targets injured knees
- Author:
- Sara Freeman
The Stop Osteoarthritis program is currently testing the feasibility of a three-part intervention to help prevent posttraumatic knee OA.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/February-2018/Psoriasis_NPF_01_web.jpg)
Pandemic puts patients with psoriatic disease off seeking medical help
- Author:
- Sara Freeman
Both the physical and mental health of people with psoriasis and psoriatic arthritis has been affected by the ongoing COVID-19 pandemic.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Machado_Pedro_UK_web.jpg)
Rheumatologic disease activity an important influencer of COVID-19 death risk
- Author:
- Sara Freeman
COVID-19 Global Rheumatology Alliance physician registry data highlight need to maintain adequate disease control to lower risk for death from...
News
Entinostat doesn’t overcome endocrine resistance in advanced breast cancer
- Author:
- Sara Freeman
Phase 3 results do not support use of entinostat in advanced breast cancer.
News
Study: Doctors underreport side effects of breast irradiation
- Author:
- Sara Freeman
A large study shows a mismatch between patient and physician reports of toxicity.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Moore_Halle_OH_web.jpg)
No edge for anastrozole over tamoxifen in DCIS
- Author:
- Sara Freeman
Breast cancer recurrence rates were similar at almost 12 years of follow-up.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Kunkler_Ian_Scotland_web.jpg)
Omitting postop radiotherapy doesn’t affect survival in older breast cancer patients
- Author:
- Sara Freeman
PRIME-2 study results show no drop in overall survival from omitting postop radiotherapy in older women with HR+, low-risk, early-stage breast...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Burstein_Harold_MA_web.jpg)
An all-oral option for advanced HR+, HER2– breast cancer?
- Author:
- Sara Freeman
Adding the oral taxane tesetaxel to capecitabine improved progression-free survival.
News
PENELOPE-B: Palbociclib disappoints in HR+, HER2– breast cancer
- Author:
- Sara Freeman
Adding palbociclib to endocrine therapy after neoadjuvant chemotherapy did not benefit patients with HR+, HER2-...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/uveitis_anterior_web.jpg)
JIA arthritis and uveitis flares ‘often run parallel’
- Author:
- Sara Freeman
Worsening arthritis in children with juvenile idiopathic arthritis could be a sign for needing a prompt eye examination.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Heller_Simon_UK_WEB.jpg)
‘Modest’ benefit for post-MI T2D glucose monitoring
- Author:
- Sara Freeman
Equivocal results were seen with regard to the best method to monitor blood glucose after myocardial infarction.